Cargando…
Case report: Pathological complete response to perioperative treatment of radiotherapy combined with angiogenesis inhibitor in a patient with pleomorphic liposarcoma
BACKGROUND: Liposarcomas (LPS) are mesenchymal malignancies with four principal subtypes presenting distinct molecular and clinical features. Pleomorphic liposarcoma (PLPS) is one of the rarest and most aggressive subtypes of LPS. Surgical resection is currently a preferred curative approach for loc...
Autores principales: | Zhang, Chenlu, Liu, Wenshuai, Wang, Binliang, Zhu, Na, Guo, Xi, Wang, Zhiming, Zhuang, Rongyuan, You, Yang, Zhang, Yong, Tong, Hanxing, Lu, Weiqi, Zhou, Yuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911416/ https://www.ncbi.nlm.nih.gov/pubmed/36776302 http://dx.doi.org/10.3389/fonc.2023.925233 |
Ejemplares similares
-
A novel long noncoding RNA PILRLS promote proliferation through TCL1A by activing MDM2 in Retroperitoneal liposarcoma
por: Shao, Yebo, et al.
Publicado: (2017) -
Integrated genomic and transcriptomic analysis revealed mutation patterns of de-differentiated liposarcoma and leiomyosarcoma
por: Liu, Wenshuai, et al.
Publicado: (2020) -
Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3
por: Zhang, Yong, et al.
Publicado: (2019) -
Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN
por: Guo, Xi, et al.
Publicado: (2022) -
Efficacy and Resistance of ALK Inhibitors in Two Inflammatory Myofibroblastic Tumor Patients with ALK Fusions Assessed by Whole Exome and RNA Sequencing
por: Zhang, Chenlu, et al.
Publicado: (2020)